Medical Marijuana, Inc.
Underestimation
| Parameter | Grade | Value | Sector average | Difference with sector, % | Average for 5 years | Difference from average, % |
|---|---|---|---|---|---|---|
| P/E |
0/10
|
0 | 31.48 | -100% | -2.87 | -100% |
| P/S |
|
0.9861 | 3.24 | -69.56% |
|
|
| P/BV |
|
0.332 | 3.36 | -90.12% |
|
|
| P/FCF |
|
0 | 21.26 | -100% |
|
|
| Ev/Ebitda |
|
-4.62 | 9.95 | -146.41% |
|
|
| Ev/S |
|
1.17 | 1.89 | -38.39% |
|
|
| Ev/FCF |
|
-2.84 | 19.96 | -114.23% |
|
|
| E/P |
|
0 | 1.47 | -100% |
|
|
Efficiency
| Parameter | Grade | Value | Sector average | Difference with sector, % | Average for 5 years | Difference from average, % |
|---|---|---|---|---|---|---|
| Ebitda margin |
0/10
|
-25.24 | 24.35 | -203.67% | -18.9 | +33.51% |
| ROE |
|
-10.18 | 13.19 | -177.2% |
|
|
| ROA |
|
-7.31 | 6.14 | -219.09% |
|
|
| ROIC |
|
0 | 15.56 | -100% |
|
|
| ROS |
|
-30.24 | 12.56 | -340.78% |
|
|
| ROCE |
|
-9 | 14.36 | -162.66% |
|
|
Debt
| Parameter | Grade | Value | Sector average | Difference with sector, % | Average for 5 years | Difference from average, % |
|---|---|---|---|---|---|---|
| Debt/Ebitda |
10/10
|
-0.872 | 6.21 | -114.04% | -1.35 | -35.26% |
| Nеt Debt/Ebitda |
|
-0.7131 | -5.72 | -87.54% |
|
|
| Debt/Ratio |
|
0.0532 | 0.2122 | -74.93% |
|
|
| Debt/Equity |
|
0 | 12.49 | -100% |
|
|
| Debt/Net Income |
|
-0.7278 | 15.05 | -104.83% |
|
|
Dividends
| Parameter | Grade | Value | Sector average | Difference with sector, % | Average for 5 years | Difference from average, % |
|---|---|---|---|---|---|---|
| Dividend yield |
0/10
|
0 | 1.76 | -100% | 0 | 0% |
| Number of years of dividend growth |
|
0 | 1.21 | -100% | ||
| DSI |
|
0 | 0.7783 | -100% |
|
|
| Average dividend growth |
|
0 | -269.81 | -100% |
|
|
| Average percentage for 5 years |
|
0 | 2.8 | -100% |
|
|
| Average percentage for payments |
|
0.3466 | 246.79 | -99.86% |
|
|
| Difference from average difference in sector |
|
-1.76 |
Growth impulse
| Parameter | Grade | Value | Sector average | Difference with sector, % | ||
|---|---|---|---|---|---|---|
| Growth impulse Revenue in 5 years |
0/10
|
-77.76 | 140.59 | -155.31% | ||
| Growth impulse Ebitda in 5 years |
|
-529.04 | 107.17 | -593.65% | ||
| Growth impulse Net Income in 5 years |
|
-106.02 | 123.16 | -186.08% | ||
| Growth impulse FCF in 5 years |
|
-108.06 | 93.68 | -215.35% | ||
| Growth impulse EPS in 5 years |
|
-103.53 | 229.02 | -145.21% |
IP Score
3.23/10
